DENTSPLY SIRONA Q1 EPS Estimate Reduced by Zacks Research

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research report issued on Thursday, March 20th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplier will post earnings per share of $0.31 for the quarter, down from their prior forecast of $0.42. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.81 EPS, Q1 2026 earnings at $0.34 EPS, Q2 2026 earnings at $0.48 EPS, Q3 2026 earnings at $0.49 EPS, Q4 2026 earnings at $0.58 EPS, FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.19 EPS.

A number of other research analysts also recently commented on the stock. Evercore ISI reissued an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Finally, Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Twelve equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $23.33.

DENTSPLY SIRONA Trading Up 1.5 %

NASDAQ XRAY opened at $15.80 on Monday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a 50 day moving average of $17.86 and a 200-day moving average of $20.40. DENTSPLY SIRONA has a 12 month low of $14.78 and a 12 month high of $33.42. The company has a market cap of $3.14 billion, a PE ratio of -7.63, a PEG ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 0.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in XRAY. Pacer Advisors Inc. raised its holdings in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. Nuance Investments LLC increased its position in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after purchasing an additional 2,708,097 shares during the period. Norges Bank acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $45,730,000. AQR Capital Management LLC lifted its position in DENTSPLY SIRONA by 245.1% during the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier’s stock worth $54,389,000 after purchasing an additional 2,054,767 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after buying an additional 1,975,404 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.